| Literature DB >> 16299590 |
Peter Sperisen1, Christoph D Schmid, Philipp Bucher, Olav Zilian.
Abstract
There are a variety of bacterial defense strategies to survive in a hostile environment. Generation of extracellular polysaccharides has proved to be a simple but effective strategy against the host's innate immune system. A comparative genomics approach led us to identify a new protein family termed Stealth, most likely involved in the synthesis of extracellular polysaccharides. This protein family is characterized by a series of domains conserved across phylogeny from bacteria to eukaryotes. In bacteria, Stealth (previously characterized as SacB, XcbA, or WefC) is encoded by subsets of strains mainly colonizing multicellular organisms, with evidence for a protective effect against the host innate immune defense. More specifically, integrating all the available information about Stealth proteins in bacteria, we propose that Stealth is a D-hexose-1-phosphoryl transferase involved in the synthesis of polysaccharides. In the animal kingdom, Stealth is strongly conserved across evolution from social amoebas to simple and complex multicellular organisms, such as Dictyostelium discoideum, hydra, and human. Based on the occurrence of Stealth in most Eukaryotes and a subset of Prokaryotes together with its potential role in extracellular polysaccharide synthesis, we propose that metazoan Stealth functions to regulate the innate immune system. Moreover, there is good reason to speculate that the acquisition and spread of Stealth could be responsible for future epidemic outbreaks of infectious diseases caused by a large variety of eubacterial pathogens. Our in silico identification of a homologous protein in the human host will help to elucidate the causes of Stealth-dependent virulence. At a more basic level, the characterization of the molecular and cellular function of Stealth proteins may shed light on fundamental mechanisms of innate immune defense against microbial invasion.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16299590 PMCID: PMC1285062 DOI: 10.1371/journal.pcbi.0010063
Source DB: PubMed Journal: PLoS Comput Biol ISSN: 1553-734X Impact factor: 4.475
Figure 1Multiple Alignments of CRs
Multiple alignments of the four CRs for a representative set of protein sequences (>15% dissimilarity over all four CRs) are shown. Sequences are identified by a species code (see Table 1), protein name (from literature as proposed in this paper), and database accession number, where available. The lengths of the sequences omitted between or within CRs are indicated in square brackets. The last row shows the secondary structure prediction obtained by jnetpred [65] for the human Stealth protein, where H stands for helices and E for beta-sheets. The color scheme used is the ClustalX default scheme, with the colors for conserved amino acids being more intense than those for nonconserved ones.
Figure 2Domain Architecture and Genome Structure
(A) CR1 to CR4, found through multiple alignments, are represented by rectangles ranging from light blue (CR1) to dark blue (CR4). Other motifs are represented as follows: predicted signal peptides as magenta rectangles, transmembrane regions as orange rectangles, Lin-12/Notch repeats as red pentagons, and EF-hands as green circles.
(B) The genome structure of the human and fly Stealth homologs is represented, with the exons depicted as green rectangles separated by introns of indicated size.
(C) Two splice variants lead to different N-terminal sequences, as supported by mouse EST sequences. Splicing reconstructs a codon for tyrosine (Y). Both proteins contain a predicted signal peptide.
Summary of All Species Containing Stealth Proteins
Figure 3Phylogenetic Tree
Trees were calculated from amino acid sequence alignments of the four CRs. As in Figure 1, sequences are identified by a species code (see Table 1), protein name (from literature as proposed in this paper), and database accession number, and are color-coded. Dissimilarities are represented by the length of the branches (all with posterior probabilities above 0.95).
Continued